Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

Cadavid, Diego; Balcer, Laura; Galetta, Steven; Aktas, Orhan; Ziemssen, Tjalf; Vanopdenbosch, Ludo; Frederiksen, Jette; Skeen, Mark; Jaffe, Glenn J.; Butzkueven, Helmut; Ziemssen, Focke; Massacesi, Luca; Chai, Yi; Xu, Lei; Freeman, Stefanie

dc.contributor.author	Ziemssen, Focke
dc.date.accessioned	2018-02-16T14:40:49Z
dc.date.available	2018-02-16T14:40:49Z
dc.date.issued	2017
dc.identifier.issn	1474-4465
dc.identifier.uri	http://hdl.handle.net/10900/80580
dc.language.iso	en	de_DE
dc.publisher	Elsevier Science Inc	de_DE
dc.relation.uri	https://doi.org/10.1016/S1474-4422(16)30377-5	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01678
utue.publikation.seiten	189-199	de_DE
utue.personen.roh	Cadavid, Diego
utue.personen.roh	Balcer, Laura
utue.personen.roh	Galetta, Steven
utue.personen.roh	Aktas, Orhan
utue.personen.roh	Ziemssen, Tjalf
utue.personen.roh	Vanopdenbosch, Ludo
utue.personen.roh	Frederiksen, Jette
utue.personen.roh	Skeen, Mark
utue.personen.roh	Jaffe, Glenn J.
utue.personen.roh	Butzkueven, Helmut
utue.personen.roh	Ziemssen, Focke
utue.personen.roh	Massacesi, Luca
utue.personen.roh	Chai, Yi
utue.personen.roh	Xu, Lei
utue.personen.roh	Freeman, Stefanie
dcterms.isPartOf.ZSTitelID	Lancet Neurology	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	16	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE